Infinity Pharmaceuticals Current Asset

INFI -- USA Stock  

USD 1.91  0.07  3.54%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Current Asset Analysis

Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Infinity Pharmaceuticals 
Current Asset 
Liquid Assets 
254.7 M

Current Asset Over Time Pattern

 Infinity Pharmaceuticals Current Assets 

About Current Asset

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
Compare to competition

Infinity Pharmaceuticals Current Asset Assessment


Infinity Pharmaceuticals Asset Growth Over Time

Total Assets

Current Assets

In accordance with recently published financial statements Infinity Pharmaceuticals has Current Asset of 254.7 M. This is 83.32% lower than that of the Healthcare sector, and significantly higher than that of Pharmaceutical Products industry, The Current Asset for all stocks is 99.31% higher than the company.

Peer Comparison

Infinity Pharmaceuticals Current Asset Comparison
  Current Asset 
      Infinity Pharmaceuticals Comparables 
Infinity Pharmaceuticals is currently under evaluation in current asset category among related companies.

Current Infinity Pharmaceuticals financial ratios